Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

351 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Reply to Arya and Agarwal.
Dorlo TP, Ostyn BA, Beijnen JH, Boelaert M, Dujardin JC, Rijal S. Dorlo TP, et al. Among authors: boelaert m. Clin Infect Dis. 2013 Sep;57(6):917-8. doi: 10.1093/cid/cit388. Epub 2013 Jun 11. Clin Infect Dis. 2013. PMID: 23759350 No abstract available.
Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance.
Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC. Rijal S, et al. Among authors: boelaert m. Clin Infect Dis. 2013 Jun;56(11):1530-8. doi: 10.1093/cid/cit102. Epub 2013 Feb 20. Clin Infect Dis. 2013. PMID: 23425958
Reply to Das.
Dujardin JC, Bhattarai NR, Rai K, Vanaerschot M, Uranw S, Ostyn BA, Boelaert M, Rijal S. Dujardin JC, et al. Among authors: boelaert m. Clin Infect Dis. 2013 Nov;57(9):1365-6. doi: 10.1093/cid/cit510. Epub 2013 Aug 13. Clin Infect Dis. 2013. PMID: 23943823 No abstract available.
Genetic markers for SSG resistance in Leishmania donovani and SSG treatment failure in visceral leishmaniasis patients of the Indian subcontinent.
Vanaerschot M, Decuypere S, Downing T, Imamura H, Stark O, De Doncker S, Roy S, Ostyn B, Maes L, Khanal B, Boelaert M, Schönian G, Berriman M, Chappuis F, Dujardin JC, Sundar S, Rijal S. Vanaerschot M, et al. Among authors: boelaert m. J Infect Dis. 2012 Sep 1;206(5):752-5. doi: 10.1093/infdis/jis424. Epub 2012 Jun 29. J Infect Dis. 2012. PMID: 22753945 Free PMC article.
Treatment of visceral leishmaniasis: pitfalls and stewardship.
Dorlo TPC, Ostyn BA, Uranw S, Dujardin JC, Boelaert M. Dorlo TPC, et al. Among authors: boelaert m. Lancet Infect Dis. 2016 Jul;16(7):777-778. doi: 10.1016/S1473-3099(16)30091-3. Lancet Infect Dis. 2016. PMID: 27352756 No abstract available.
Clinical and parasite species risk factors for pentavalent antimonial treatment failure in cutaneous leishmaniasis in Peru.
Llanos-Cuentas A, Tulliano G, Araujo-Castillo R, Miranda-Verastegui C, Santamaria-Castrellon G, Ramirez L, Lazo M, De Doncker S, Boelaert M, Robays J, Dujardin JC, Arevalo J, Chappuis F. Llanos-Cuentas A, et al. Among authors: boelaert m. Clin Infect Dis. 2008 Jan 15;46(2):223-31. doi: 10.1086/524042. Clin Infect Dis. 2008. PMID: 18171254
351 results